سعر سيتارابين 500مجم/10مل فيال 2022

Cytarabine 500 mg/10 mL injectable for oncology use (IV/SC/IT as labelled).

• Remission induction in acute non-lymphocytic leukemia (adults/pediatrics) in combination regimens; also useful in ALL and CML blast phase; intrathecal prophylaxis/treatment of meningeal leukemia (preservative-free) (US label). Confirm Egyptian leaflet.Population: As per labelled oncology indicationsDailyMed

• Expected: anemia, leukopenia, thrombocytopenia; nausea/vomiting (esp. rapid IV), diarrhea, oral ulceration, hepatic dysfunction, fever, rash; cytarabine syndrome (fever, myalgia, rash, conjunctivitis).International label, same formulation · DailyMed

• Hypersensitivity to cytarabine.International label, same formulation · DailyMed

• BOXED-style warning: potent myelosuppression (leukopenia, thrombocytopenia, anemia); use only by physicians experienced in cancer chemotherapy with adequate supportive facilities. High-dose regimens: severe CNS/GI/pulmonary toxicity reported.International label, same formulation · DailyMed

• Digoxin (oral)ModerateCombination chemo including cytarabine may decrease digoxin levels; monitor.DailyMed
• GentamicinMinorIn vitro antagonism vs K. pneumoniae susceptibility reported.DailyMed

• Can cause fetal harm; teratogenic in animals; advise women of childbearing potential to avoid pregnancy.International label, same formulation · DailyMed

• Cytarabine: S-phase-specific cytotoxic nucleoside analogue: converted intracellularly to ara-CTP, which inhibits DNA polymerase and is incorporated into DNA; inactivated by cytidine deaminase to ara-U.